A once-daily antiinflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study Group.

J. C. Bass*, B. H. Athreya, E. J. Brewer, E. H. Giannini, D. P. Goldsmith, J. R. Hollister, D. W. Kredich, N. E. Brandstrup, J. J. Miller, L. M. Pachman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A once-daily antiinflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study Group.'. Together they form a unique fingerprint.